3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase EARLY_PHASE1
1
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Triple Negative Breast Neoplasms
1
Breast Neoplasms
1
Interventions
Letrozole
7
Fluorodeoxyglucose F18
7
Magnetic Resonance Spectroscopy
5
Blood Specimen Collection
5
pembrolizumab
4
atezolizumab
4
Trastuzumab
4
Oncolytic Virotherapy
4
Bevacizumab
4
palbociclib
3
Saline Solution
3
Fish Oils
3
Docosahexaenoic Acids
3
Denosumab
3
Carboplatin
3
Biopsy
3
pertuzumab
2
olaparib
2
Vitamin D
2
Vinorelbine
2
Taxes
2
Sentinel Lymph Node Biopsy
2
Radiotherapy
2
Positron-Emission Tomography
2
Positron Emission Tomography Computed Tomography
2
Paclitaxel
2
Omacor
2
Neoadjuvant Therapy
2
Metformin
2
Lapatinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Breast Neoplasms
×
reolysin
×
Clear all
NCT04102618
2022-08-15
AWARE-1
Oncolytics Biotech
Phase EARLY_PHASE1
Terminated
26 enrolled